| Meredith Gault Brown, MD | |
|
1111 6th Ave, Des Moines, IA 50314-2613 | |
| (515) 247-3173 | |
| Not Available |
| Full Name | Meredith Gault Brown |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 15 Years |
| Location | 1111 6th Ave, Des Moines, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639306574 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MT195684 (Pennsylvania) | Secondary |
| 207P00000X | Emergency Medicine | 40052 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hermann Katy Hospital | Katy, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Memorial Hermann Hospital Based Physician Group | 4385075480 | 239 |
News Archive
New research suggests that GlycA, a newly identified blood marker, and C-reactive protein both independently predict major adverse cardiac events, including heart failure and death. Patients who have high levels of both biomarkers are at especially high risk.
Toxoplasma gondii is a common parasite which causes the development of fatal encephalosis or pneumonia in immunodeficient patients under treatment of AIDS or cancer.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that it has initiated a randomized Phase 1b/2 clinical trial evaluating IPI-926, its novel, oral Hedgehog pathway inhibitor, in combination with gemcitabine in patients with pancreatic cancer.
Increased awareness of breast tissue density masking cancer and thus decreasing the diagnostic sensitivity of mammography has brought about relevant state-level policies.
› Verified 4 days ago
| Entity Name | Acs Primary Care Physicians Southwest Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538101019 PECOS PAC ID: 1850204363 Enrollment ID: O20041206000027 |
News Archive
New research suggests that GlycA, a newly identified blood marker, and C-reactive protein both independently predict major adverse cardiac events, including heart failure and death. Patients who have high levels of both biomarkers are at especially high risk.
Toxoplasma gondii is a common parasite which causes the development of fatal encephalosis or pneumonia in immunodeficient patients under treatment of AIDS or cancer.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that it has initiated a randomized Phase 1b/2 clinical trial evaluating IPI-926, its novel, oral Hedgehog pathway inhibitor, in combination with gemcitabine in patients with pancreatic cancer.
Increased awareness of breast tissue density masking cancer and thus decreasing the diagnostic sensitivity of mammography has brought about relevant state-level policies.
› Verified 4 days ago
| Entity Name | Memorial Hermann Hospital Based Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295363497 PECOS PAC ID: 4385075480 Enrollment ID: O20200505001521 |
News Archive
New research suggests that GlycA, a newly identified blood marker, and C-reactive protein both independently predict major adverse cardiac events, including heart failure and death. Patients who have high levels of both biomarkers are at especially high risk.
Toxoplasma gondii is a common parasite which causes the development of fatal encephalosis or pneumonia in immunodeficient patients under treatment of AIDS or cancer.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that it has initiated a randomized Phase 1b/2 clinical trial evaluating IPI-926, its novel, oral Hedgehog pathway inhibitor, in combination with gemcitabine in patients with pancreatic cancer.
Increased awareness of breast tissue density masking cancer and thus decreasing the diagnostic sensitivity of mammography has brought about relevant state-level policies.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Meredith Gault Brown, MD 1111 6th Ave, Des Moines, IA 50314-2613 Ph: () - | Meredith Gault Brown, MD 1111 6th Ave, Des Moines, IA 50314-2613 Ph: (515) 247-3173 |
News Archive
New research suggests that GlycA, a newly identified blood marker, and C-reactive protein both independently predict major adverse cardiac events, including heart failure and death. Patients who have high levels of both biomarkers are at especially high risk.
Toxoplasma gondii is a common parasite which causes the development of fatal encephalosis or pneumonia in immunodeficient patients under treatment of AIDS or cancer.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that it has initiated a randomized Phase 1b/2 clinical trial evaluating IPI-926, its novel, oral Hedgehog pathway inhibitor, in combination with gemcitabine in patients with pancreatic cancer.
Increased awareness of breast tissue density masking cancer and thus decreasing the diagnostic sensitivity of mammography has brought about relevant state-level policies.
› Verified 4 days ago
Myles Kawamura, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Ave, Emergency Department, Des Moines, IA 50314 Phone: 515-247-3211 Fax: 515-643-8933 | |
Brooke Johnson, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Pleasant St, Des Moines, IA 50309 Phone: 515-241-6262 | |
Hijinio G. Carreon, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Ave, Emergency Department, Des Moines, IA 50314 Phone: 515-247-4445 | |
Dr. Chad William Becker, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Pleasant St, Des Moines, IA 50309 Phone: 515-241-6412 | |
Dr. Kevin Pothoven, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Ave, Des Moines, IA 50314 Phone: 515-247-3211 Fax: 515-643-8722 | |
Dr. Anastasia Maria Marx, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Pleasant St, Des Moines, IA 50309 Phone: 515-241-6212 | |
Dr. Benjamin R Sweet, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 6th Ave, Des Moines, IA 50314 Phone: 515-247-3121 |